Modern Management Options for Ph+ ALL

SIMPLE SUMMARY: The use of tyrosine kinase inhibitors has represented a major step forward in the therapy of Philadelphia chromosome positive acute lymphoblastic leukemia. Recent improvements in the therapy are focused on early use of third generation tyrosine kinase inhibitors, their combination wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribera, Josep-Maria, Chiaretti, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558985/
https://www.ncbi.nlm.nih.gov/pubmed/36230478
http://dx.doi.org/10.3390/cancers14194554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558985/
https://www.ncbi.nlm.nih.gov/pubmed/36230478
http://dx.doi.org/10.3390/cancers14194554

Ejemplares similares